What do TPO and thyroglobulin antibodies mean?
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Short answer
TPO and thyroglobulin antibodies are immune proteins directed at the thyroid. Their presence identifies autoimmune thyroid disease, usually Hashimoto's thyroiditis, and explains why a thyroid is failing. The antibody number does not measure how sick the thyroid is, does not need repeating, and many people with positive antibodies have completely normal thyroid function.
Thyroid peroxidase antibodies and thyroglobulin antibodies are made by the immune system against two thyroid proteins. Measuring them answers a cause question rather than a function question. A positive result tells you that autoimmune thyroid disease is present, which in practice usually means Hashimoto's thyroiditis. It does not tell you how underactive the thyroid is, and it does not by itself require treatment.
What each antibody marks
Thyroid peroxidase is the enzyme that attaches iodine to thyroglobulin to build thyroid hormone, so TPO antibodies are the more informative of the two. The National Institute of Diabetes and Digestive and Kidney Diseases describes thyroid peroxidase antibodies as present in most people with Hashimoto's disease. Thyroglobulin antibodies are added when TPO antibodies are negative but autoimmune disease is still suspected, and they matter separately after thyroid cancer surgery, where they interfere with thyroglobulin tumour marker measurement.
Positive antibodies with normal thyroid function
Positive TPO antibodies are common in the general population. In the NHANES III United States survey, 11.3 percent of the disease-free reference population tested positive. Most of those people have normal TSH and free T4 and will never need levothyroxine. What antibody positivity does change is risk over time: rates of progression from subclinical to overt hypothyroidism run roughly 2 to 6 percent per year overall and around 3 to 8 percent per year when TPO antibodies are positive. That is a reason to check TSH periodically, not a reason to start medication.
Why the antibody number should not be tracked
Antibody titres fluctuate without any change in thyroid function, and watching them causes distress with no clinical payoff. The American Thyroid Association states plainly that "repeating and monitoring your thyroid antibody levels is not needed," adding that TSH and free T4 are what report actual thyroid function. A falling TPO titre after a diet change is not evidence the disease is improving, and a rising titre in someone with a stable TSH does not call for a dose increase.
| Antibody | What a positive result means | Repeat it? |
|---|---|---|
| TPO antibody | Autoimmune thyroid disease, usually Hashimoto's | No |
| Thyroglobulin antibody | Supports autoimmunity when TPO is negative; interferes with thyroglobulin monitoring after thyroid cancer | Only in thyroid cancer follow-up |
| TSH receptor antibody (TRAb or TSI) | Graves' disease, an overactive thyroid | Yes, in Graves' management |
Have TPO antibodies checked once to establish the cause, then follow TSH rather than the antibody. If your antibodies are positive and your thyroid function is normal, an annual TSH is usually enough, with earlier testing if you become pregnant or develop symptoms.
The clinical detail
TPO antibody assays are not standardised across manufacturers, so titres are not comparable between platforms and a change in absolute number often reflects an assay change rather than disease activity. Cut-offs vary from roughly 9 to 35 IU/mL depending on the method.
TSH receptor antibody is a different analyte with a different purpose. The 2016 American Thyroid Association hyperthyroidism guideline notes that a positive thyrotropin receptor antibody confirms Graves' disease as the cause of thyrotoxicosis and is cost effective compared with proceeding straight to a radioiodine uptake scan. In pregnancy, TSH receptor antibody titres are followed because the antibody crosses the placenta and can affect the fetal thyroid, whereas TPO antibody titres are not followed. The 2026 American Thyroid Association pregnancy guideline gives a strong recommendation against offering levothyroxine to euthyroid TPO or thyroglobulin antibody positive women with infertility.
Written and medically reviewed by Zahraa Sater, M.D., M.P.H.
Reviewed August 12, 2026 · Next review due August 12, 2028
Sources
- Hashimoto's Thyroiditis. American Thyroid Association
- Hashimoto's Disease. National Institute of Diabetes and Digestive and Kidney Diseases
- Serum TSH, T4, and Thyroid Antibodies in the United States Population (NHANES III). Journal of Clinical Endocrinology and Metabolism. PMID 11836274
- Subclinical Hypothyroidism. StatPearls, National Library of Medicine
- American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum. American Thyroid Association. PMID 42219800
This library is educational and is not individual medical advice. Read our Editorial and Medical Review Policy.